Skip to main navigation Skip to search Skip to main content

Channeling of antidepressant drugs to patients with cardiovascular disease

  • Maastricht University

Research output: Contribution to journal › Article › Professional

Abstract

Antidepressant drugs differ in their propensity to cause cardiac side-effects. Claimed advantages of a drug may channel it to patients with special pre-existing morbidity, with the consequence that patient characteristics may be confounded with drug effects. We measured the relative usage of the various antidepressant drugs in patients with and without cardiovascular disease, particularly to learn whether antidepressant drugs without cardiac side-effects were more likely to be prescribed for patients with concomitant cardiovascular conditions. Our primary data were the drug-dispensing records from Dutch community pharmacies, covering 1173 anonymized recipients of antidepressant drugs in a 6-month period. We interpreted as marker of cardiovascular disease the concomitant prescribing of major cardiovascular drugs, such as cardiac glycosides, beta blockers, calcium antagonists and the like. The differences in the percentage of recipients of antidepressant drugs concomitantly prescribed major cardiac agents were considerable. At the high end were mianserin (36%) and doxepin (35%); at the low end were fluoxetine (13%) and clomipramine (18%). When the data were stratified for age and sex, however, no significant residual differences remained with respect to cardiovascular co-medication. Thus, channeling occurs in some drugs, but apparently partly via the indirect way of age/sex differences of the recipients of the drugs.

Original languageEnglish
Pages (from-to)159-167
Number of pages9
JournalPost Marketing Surveillance
Volume5
Issue number2
Publication statusPublished - 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • adverse drug reactions
  • antidepressant drugs
  • cardiac disease
  • mental depression
  • pharmacoepidemiology

Fingerprint

Dive into the research topics of 'Channeling of antidepressant drugs to patients with cardiovascular disease'. Together they form a unique fingerprint.

Cite this